Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantation.

JeffreyR. Schriber(Stanford University), Samuel Strober(Palo Alto University), N Ginzton(Stanford University), RS Negrin(Stanford University), B.J. Still, Peter L. Greenberg, C. Kusnierz-Glaz(Stanford University), Sussan Dejbakhsh‐Jones(Stanford University)

PubMed

August 1, 1995

Cited by 18

Related Papers

Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.

|The Journal of Experimental Medicine|1991|623

Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy

|Blood|1993|284

Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy

|Blood|1996|209

Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells

|Blood|1996|193

Chimerism, Graft Survival, and Withdrawal of Immunosuppressive Drugs in HLA Matched and Mismatched Patients After Living Donor Kidney and Hematopoietic Cell Transplantation

|American Journal of Transplantation|2015|192